Effect of Dentoxol® in the treatment of recurrent mild aphthous ulcers. A prospective observational pilot study
Int. j interdiscip. dent. (Print)
;
15(1): 25-28, abr. 2022. tab, graf
Article
Dans Anglais
| LILACS
| ID: biblio-1385244
ABSTRACT
ABSTRACT Background:
Recurrent aphthous stomatitis (RAS) is the most common oral ulceration. Its prevalence in the general population varies between 5% and 60%, and during the acute period, it causes pain and interferes with basic activities, such as eating, swallowing and talking. Dentoxol® is a medical mouthrinse that cleans, moisturizes and lubricates the mouth, mechanically stimulating local epithelial regeneration. The aim of this study was to evaluate the efficacy of Dentoxol® in improving the general state of patient with minor RAS using two different treatment schemes. Material andmethods:
Thirty-nine patients with RAS were recruited in a prospective observational pilot study. Two dosing regimens, 5 ml of Dentoxol® twice daily and 5 ml of Dentoxol® three times daily were evaluated.Results:
Efficacy to improve the general state was significant superior in "Three time daily" group compared with "twice daily" at 72 h (66% vs 33% respectively). No pain was reported in approximately 90% of cases at 96 h of use in both group without significant differences between the groups in any evaluation time-point.Conclusion:
Despite the limitations of these preliminary data, Dentoxol® shows promising beneficial properties for the management of minor RAS.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Stomatite aphteuse
/
Ulcère buccal
Type d'étude:
Facteurs de risque
Limites du sujet:
Adolescent
/
Adulte
/
Humains
langue:
Anglais
Texte intégral:
Int. j interdiscip. dent. (Print)
Thème du journal:
Medicina Cl¡nica
/
Odontologia
/
Patologia
Année:
2022
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Ingalfarma SpA/CL
/
Universidad Mayor/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS